Patients' Pain Anxiety Levels Vary Depending on the Type of Pain, the Patient's Gender, and Pain Duration

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 10
Volume 5
Issue 10

Although patients with cancer pain reported lower levels of current pain than did patients with benign or treatmentrelated pain, their pain anxiety levels were higher, Mikki Miner, RN, MS, said in a poster presentation at the 8th World Congress on Pain.

BUFFALO, NY-Although patients with cancer pain reported lowerlevels of current pain than did patients with benign or treatmentrelatedpain, their pain anxiety levels were higher, Mikki Miner, RN,MS, said in a poster presentation at the 8th World Congress onPain.

Ms. Miner and her colleagues at the Roswell Park Cancer Institutesurveyed 283 outpatients on the Pain Management Service--150 withcancer pain, 40 with treatment-related pain, and 93 with chronicbenign pain--using several psychometric scales for pain anxiety.

The cancer pain patients reported lowest present pain and leastpain within 24 hours, but had higher scores on the pain anxietyscales than the other two groups.

Interestingly, of the four domains of the Pain Anxiety SymptomsScale (PASS)--fear, cognitive anxiety, escape avoidance, and somaticanxiety--females had higher levels of fear and cognitive anxietythan did men.

The study also showed a temporal pattern to pain anxiety acrossall three groups: pain anxiety was highest among patients withpain for more than 6 months but less than 1 year.

"Some of these findings are very intuitive," Ms. Minersaid. "After 6 months of pain, you become anxious. Certainly,the cancer patients would have more anxiety, and that did holdup in this study. It also makes perfect sense for the other twogroups: If you were still in pain 6 months after your trauma ortreatment, you would become anxious."

At the end of 1 year if the pain is still present, Ms. Miner speculatedthat pain anxiety levels drop because patients have either developedother coping skills or the anxiety has changed, maybe into depression.This finding could be helpful in the clinical setting, she noted,since pain and depression are treated differently.

Recent Videos
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Genetic backgrounds and ancestry may hold clues for better understanding pancreatic cancer, which may subsequently mitigate different disparities.
Factors like genetic mutations and smoking may represent red flags in pancreatic cancer detection, said Jose G. Trevino, II, MD, FACS.
Thomas Hope, MD, believes that an NRC initiative to update infiltration guidelines may organically address concerns that H.R. 2541 outlines.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
4 experts are featured in this series.
4 experts are featured in this series.
Thomas Hope, MD, had not observed an adverse effect attributable to an infiltration across more than a decade of administering nuclear agents at UCSF.
Numerous clinical trials vindicating the addition of immunotherapy to first-line chemotherapy in SCLC have emerged over the last several years.
Two experts are featured in this series.
Related Content